Intelligent Investor

Acumentis Group Limited (ASX: ACU) - Announcements

- Current share price for ACU : $0.070

ASX company news and announcements for Acumentis Group Limited (ACU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Acumentis Group Limited (ACU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Acumentis Group Limited (ACU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Acumentis Group Limited (ACU)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$15 Commitments Test Entity - Fourth Quarter Report 31 Jul 2007 5:11PM $0.051 $0.070 $0.073 risen by 37.25%
$15 Suspension from Official Quotation 11 Sep 2006 10:06AM n/a $0.070 $0.073 n/a
$15 Trading Halt 7 Sep 2006 11:19AM $0.051 $0.070 $0.073 risen by 37.25%
$15 Preliminary Results of Study 18 Aug 2006 12:14PM $0.059 $0.070 $0.073 risen by 18.64%
$15 Board Changes 18 Aug 2006 10:06AM $0.059 $0.070 $0.073 risen by 18.64%
$15 Trading Halt 16 Aug 2006 9:57AM n/a $0.070 $0.073 n/a
$15 Response to ASX Appendix 4C Query 14 Aug 2006 9:56AM $0.055 $0.070 $0.073 risen by 27.27%
$15 Commitments Test Entity - Fourth Quarter Report 1 Aug 2006 8:27AM n/a $0.070 $0.073 n/a
$15 Progress in the evaluation of RP101 8 Jun 2006 5:31PM $0.064 $0.070 $0.073 risen by 9.38%
$15 Response to ASX Query 7 Jun 2006 10:05AM $0.080 $0.070 $0.073 fallen by 12.50%
$15 Results of Pentrys trial 6 Jun 2006 2:21PM $0.090 $0.070 $0.073 fallen by 22.22%
$15 Trading Halt 6 Jun 2006 10:14AM $0.090 $0.070 $0.073 fallen by 22.22%
$15 Avantogen & Hawaii Biotech combine vaccine businesses 10 May 2006 8:53AM $0.110 $0.070 $0.073 fallen by 36.36%
$15 Commitments Test Entity - Third Quarter Report 28 Apr 2006 7:32PM $0.110 $0.070 $0.073 fallen by 36.36%
$15 Appendix 3B/Disclosure Document - Non-renounceable Issue 31 Mar 2006 10:10AM $0.124 $0.070 $0.073 fallen by 43.50%
$15 A$5.7million fully underwritten non-renouceable rights issue 27 Mar 2006 10:01AM $0.110 $0.070 $0.073 fallen by 36.13%
$15 Trading Halt 24 Mar 2006 10:21AM $0.114 $0.070 $0.073 fallen by 38.81%
$15 Half Yearly Report & Half Year Accounts 16 Mar 2006 6:13PM $0.114 $0.070 $0.073 fallen by 38.81%
$15 A$5.7 million capital raising 16 Mar 2006 10:01AM $0.124 $0.070 $0.073 fallen by 43.50%
$15 Avantogen & Hawaii Biotech to Combine Vaccine Businesses 16 Mar 2006 9:22AM $0.124 $0.070 $0.073 fallen by 43.50%
$15 Trading Halt 15 Mar 2006 11:09AM n/a $0.070 $0.073 n/a
$15 ACU & Innovate merge key oncology program RP101 2 Feb 2006 9:04AM $0.157 $0.070 $0.073 fallen by 55.47%
$15 Commitments Test Entity - Second Quarter Report 31 Jan 2006 7:57PM $0.119 $0.070 $0.073 fallen by 41.23%
$15 Appendix 3B/Disclosure Document: Non-Renouceable Issue 3 Nov 2005 10:19AM $0.137 $0.070 $0.073 fallen by 48.91%
$15 $5.7m fully underwritten Non-Renounceable Rights Issue 2 Nov 2005 11:55AM $0.132 $0.070 $0.073 fallen by 47.09%

451 - 475 of 511 results

Page 19 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.